A detailed history of Wade G W & Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Wade G W & Inc holds 2,229 shares of REGN stock, worth $1.59 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,229
Previous 2,336 4.58%
Holding current value
$1.59 Million
Previous $1.92 Million 1.87%
% of portfolio
0.06%
Previous 0.07%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

SELL
$775.18 - $881.7 $82,944 - $94,341
-107 Reduced 4.58%
2,229 $1.96 Million
Q3 2023

Nov 08, 2023

SELL
$692.45 - $844.37 $20,773 - $25,331
-30 Reduced 1.27%
2,336 $1.92 Million
Q2 2023

Aug 10, 2023

BUY
$700.03 - $830.35 $9,100 - $10,794
13 Added 0.55%
2,366 $1.7 Million
Q1 2023

May 09, 2023

SELL
$680.49 - $826.97 $41,509 - $50,445
-61 Reduced 2.53%
2,353 $1.93 Million
Q4 2022

Feb 10, 2023

BUY
$705.89 - $766.39 $24,000 - $26,057
34 Added 1.43%
2,414 $1.74 Million
Q3 2022

Nov 10, 2022

SELL
$573.97 - $724.32 $39,029 - $49,253
-68 Reduced 2.78%
2,380 $1.64 Million
Q2 2022

Aug 09, 2022

BUY
$548.35 - $738.84 $21,385 - $28,814
39 Added 1.62%
2,448 $1.45 Million
Q1 2022

May 10, 2022

SELL
$595.12 - $698.43 $167,823 - $196,957
-282 Reduced 10.48%
2,409 $1.68 Million
Q4 2021

Feb 09, 2022

BUY
$543.48 - $670.97 $32,065 - $39,587
59 Added 2.24%
2,691 $1.7 Million
Q3 2021

Nov 03, 2021

SELL
$574.03 - $680.96 $10,906 - $12,938
-19 Reduced 0.72%
2,632 $1.59 Million
Q2 2021

Aug 12, 2021

BUY
$472.8 - $558.54 $945 - $1,117
2 Added 0.08%
2,651 $1.48 Million
Q1 2021

May 05, 2021

BUY
$446.73 - $548.2 $543,670 - $667,159
1,217 Added 84.99%
2,649 $1.25 Million
Q4 2020

Feb 03, 2021

BUY
$478.3 - $607.98 $221,931 - $282,102
464 Added 47.93%
1,432 $692,000
Q3 2020

Nov 09, 2020

BUY
$544.75 - $658.21 $45,214 - $54,631
83 Added 9.38%
968 $542,000
Q2 2020

Aug 07, 2020

BUY
$493.32 - $643.92 $436,588 - $569,869
885 New
885 $552,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Wade G W & Inc Portfolio

Follow Wade G W & Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wade G W & Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wade G W & Inc with notifications on news.